Cargando…
Does timing matter when initiating elagolix in a natural menstrual cycle?
OBJECTIVE: To investigate the efficacy of elagolix when administered at different time points in a menstrual cycle. DESIGN: Clinical case series. SETTING: Academic reproductive endocrinology center. PATIENTS: Ovulatory women not desiring pregnancy. INTERVENTION(S): Six doses of elagolix 200 mg were...
Autores principales: | Danis, Rachel B., Sriprasert, Intira, Stanczyk, Frank Z., Paulson, Richard J., Winer, Sharon A., Ho, Jacqueline R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441568/ https://www.ncbi.nlm.nih.gov/pubmed/34553156 http://dx.doi.org/10.1016/j.xfre.2021.05.009 |
Ejemplares similares
-
Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation
por: Danis, Rachel B., et al.
Publicado: (2021) -
Elagolix: How far can it go in the world of gynecology?
por: Danis, Rachel B.
Publicado: (2023) -
Heavy menstrual bleeding diagnosis and medical management
por: Sriprasert, Intira, et al.
Publicado: (2017) -
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
por: Simon, James A., et al.
Publicado: (2020) -
The role of elagolix in the suppression of ovulation in donor oocyte cycles
por: Boniface, Catherine, et al.
Publicado: (2023)